Showing results (81-90 of 462) with videos related to
Sort By:
Pageof 47
Annals of Diagnostic Pathology|May 5, 2024
Dysplastic crypt-rings in tandem: A novel histologic parameter in tubular adenomasCarlos A Rubio, Michael Vieth, Corinna Lang-SchwarzVirchows Archiv : an International Journal of Pathology|November 9, 2018
BRAF mutation testing in melanoma: results from a German observational multicenter studyArndt Hartmann, Peter Schirmacher, William Sterlacci, et al.Pathology Oncology Research : POR|June 17, 2008
Idiopathic systemic amyloidosis primarily affecting the lungs with fatal pulmonary haemorrhage due to vascular involvementWilliam Sterlacci, Lothar Veits, Patrizia Moser, et al.Anticancer Research|September 27, 2015
Lectin Histochemistry Shows WGA, PHA-L and HPA Binding Increases During Progression of Human Colorectal CancerPia Hägerbäumer, Michael Vieth, Mario Anders, et al.Anticancer Research|December 31, 2021
Diagnostic and Prognostic Impact of Crypt Branching in Patients With Ulcerative Colitis: A Validation StudyCorinna Lang-Schwarz, Carlos A Rubio, Michael ViethOncotarget|October 10, 2012
Up-regulation of c-MYC and SIRT1 expression correlates with malignant transformation in the serrated route to colorectal cancerLydia Kriegl, Michael Vieth, Thomas Kirchner, et al.Anticancer Research|September 30, 2024
Nondysplastic Colon Crypts Intercalated in Tubular Adenomas Support Field CancerizationCarlos A Rubio, Michael Vieth, Corinna Lang-SchwarzJournal of Gastroenterology and Hepatology|November 10, 2024
Architectural crypt distortions in ulcerative colitis: Time for reappraisalCarlos A Rubio, Corinna Lang-Schwarz, Michael ViethJournal of Clinical Pathology|May 5, 2012
Absence of extramural venous invasion is an excellent predictor of metastasis-free survival in colorectal carcinoma stage II--a study using tangential tissue sectioningKlaus Dirschmid, William Sterlacci, Frank Oellig, et al.Human Pathology|August 16, 2011
High transforming growth factor β expression represents an important prognostic parameter for surgically resected non-small cell lung cancerWilliam Sterlacci, Dominik Wolf, Spasenija Savic, et al.Pageof 47